摘要 |
<p>The present invention relates to pharmaceutical formulations comprising cefpodoxime proxetil and clavulanic acid for use in the treatment of upper respiratory infections such as tonsillitis, sinusitis, pharyngitis, otitis media; lower respiratory tract infections such as uncomplicated upper and lower urinary tract infections, uncomplicated gonococcal urethritis, skin and soft tissue infections. Said formulations are characterized in that they are in tablet form.</p> |